These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15587536)

  • 21. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM; Davis C; Olerud J
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C. Infection, transmission, recognition, and treatment.
    Gross JB
    Minn Med; 1998 Jul; 81(7):28-32. PubMed ID: 9676109
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical aspects of hepatitis C in women of child-bearing age].
    Lombay B; Gasztonyi B; Szalay F
    Orv Hetil; 2008 Jun; 149(22):1017-21. PubMed ID: 18508735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis C in certain patient populations: children, patients with hemophilia and thalassemia, the hemodialyzed and kidney transplant recipients].
    Fontaine H
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B91-104. PubMed ID: 12180314
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis B and C in children.
    Hsu EK; Murray KF
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jun; 5(6):311-20. PubMed ID: 18414457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C.
    Steven ID; Gill JS; Hall R
    Aust Fam Physician; 1994 Sep; 23(9):1747-8. PubMed ID: 7980174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rational approach to hepatitis C.
    Mills P; McPeake J; McCruden E
    Practitioner; 1996 Mar; 240(1560):172-6. PubMed ID: 8710731
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis C virus infection in dialysis patients.
    Sułowicz W; Radziszewski A; Chowaniec E
    Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-ribavirin-associated ischemic colitis.
    Punnam SR; Pothula VR; Gourineni N; Punnam A; Ranganathan V
    J Clin Gastroenterol; 2008 Mar; 42(3):323-5. PubMed ID: 18223489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HCV infection today].
    Vespasiani Gentilucci U; D'Avola D; Picardi A
    Clin Ter; 2003; 154(3):149-50. PubMed ID: 12910802
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis C. The surprise infectious disease of the decade.
    Mayo Clin Health Lett; 1998 Feb; 16(2):6. PubMed ID: 9516363
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatitis C today].
    Bourlière M
    Soins; 1999 Dec; (641):33-6. PubMed ID: 10857435
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serum smooth muscle antibodies with anti-actin specificity appeared during treatment with interferon alpha].
    Grimbert S; Mohib S; Johannet C; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 1996; 20(4):404-5. PubMed ID: 8758511
    [No Abstract]   [Full Text] [Related]  

  • 38. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C.
    Latin American Association for the Study of the Liver
    Ann Hepatol; 2010; 9 Suppl():8-26. PubMed ID: 20713990
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C: speaking out about the silent epidemic.
    Parini S
    Nurs Manage; 2001 Jun; 32(6):18-23; quiz 23-4. PubMed ID: 15103863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
    Pascal JP
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.